Carolin T. Lehner

Carolin T. Lehner

Auto-generated profile, based on publicly available information

Carolin T. Lehner

Chair of Epidemiology, School of Medicine and Health, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Diabetologia
Verified
Journal Article
Open access
PDF file
CLCarolin T. Lehner
Carolin T. Lehner
MEMarian Eberl
Marian Eberl
EDEwan Donnachie
Ewan Donnachie
LTLuana F. Tanaka
Luana F. Tanaka
GSGunther Schauberger
Gunther Schauberger
SKStefanie J. Klug
Stefanie J. Klug
Aims/hypothesis: The aim of the study is to describe the time trend of type 2 diabetes incidence in the largest state of Germany, Bavaria, from 2012 to 2021, and to compare the incidence rates during the pandemic period (2020–2021) to the pre-pandemic period (2012–2019). Methods: This secondary data analysis uses health claims data provided by the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering approximately 11 million insurees, accounting for 85% of the total population of Bavaria, Germany. Newly diagnosed type 2 diabetes cases in adults (≥20 years) coded as E11 (Diabetes mellitus, Type 2) or E14 (Unspecified diabetes mellitus) under ICD-10, German modification (ICD-10-GM) for the study period 2012 to 2021 were included. Annual and quarterly age-standardised incidence rates (ASIR) stratified by sex, age and region were calculated using the European standard population. Sex-specific crude incidence rates (CIR) were calculated using 10-year age groups. Regression analyses adjusted for time trends, seasonal effects, and pandemic effects were used to analyse the incidence trend and to assess the effect of the pandemic. Results: Overall, 745,861 new cases of type 2 diabetes were diagnosed between 2012 and 2021: 50.4% (376,193 cases) in women. The male/female ratio remained stable over the observation period, while the median age at diagnosis decreased from 62 to 59 years in men and from 66 years to 61 years in women. ASIR were consistently higher for men compared with women, with the yearly difference remaining stable over time (2012: 18%; 2021: 20%). An overall decreasing trend in ASIR was observed during the study period, with a strong decrease from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021 for both sexes. For men, ASIR decreased from 1514 per 100,000 person-years in 2012 to 995 per 100,000 person-years in 2021 (4.6% average annual reduction), and for women from 1238 per 100,000 person-years in 2012 to 796 per 100,000 person-years in 2021 (4.8% average annual reduction). This downward trend was also observed for age groups above 50 years. Regression analyses showed no significant change in incidence rates during the pandemic period (2020 and 2021) compared with the pre-pandemic period. Conclusions/interpretation: For the first time, a 10-year incidence trend of type 2 diabetes is reported for Germany, showing a strong decline from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021. The incidence trend of type 2 diabetes appears not to have been affected by the first 2 years of the COVID-19 pandemic. Despite an overall increasing prevalence, the incidence is decreasing, potentially resulting from robust screening by family physicians, reducing the median age at diagnosis by 3 to 5 years. However, further investigation is needed to fully identify the reasons for the declining incidence trend. Continued incidence monitoring is necessary to identify the long-term trend and the potential effect of the pandemic on diagnoses of type 2 diabetes. Graphical


2 June 2026 in European Journal of Epidemiology
Verified
Journal Article
Open access
CLCarolin T. Lehner
Carolin T. Lehner
IAIvona Anastasova
Ivona Anastasova
GSGunther Schauberger
Gunther Schauberger
MEMarian Eberl
Marian Eberl
FSFlorian Schederecker
Florian Schederecker
SKStefanie J. Klug
Stefanie J. Klug
Type 1 Diabetes (T1D) is a common chronic autoimmune disorder in children and adolescents worldwide. We described the development of T1D incidence from 2012 to 2021 and compared the incidence of the pre-pandemic period (2012–2019) with the pandemic period (2020–2021) in Bavaria, Germany. Routinely collected health claims from the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering a population of 2 million children and adolescents (aged ≤ 19 years), were used. All cases of newly diagnosed T1D (ICD-10-GM E10) were included. Sex-specific annual and quarterly crude incidence rates (CIR) and age-standardized incidence rates (ASIR) were calculated. Sex-specific CIRs were calculated by 5-year age groups. Interrupted time series analysis was used to analyze trend changes in the pandemic versus the pre-pandemic period. From 2012 to 2021, 5,762 incident cases were identified in Bavaria. Overall, an increasing incidence was observed with an average annual increase of 3.7% in females (from 23.5 in 2012 to 32.5 per 100,000 person-years (py) in 2021) and 5.0% in males (from 25.2 to 38.9 per 100,000 py). The increase was highest in age groups 0–4 (12.4%) in males and 15–19 (8.5%) in females. Regression analysis showed no clear level or slope change in T1D incidence for both sexes during the pandemic period. When accounting for non-linear trends, a statistically significant level change was observed for females during the pandemic period (ß=7.66, 95% CI 0.23, 15.09), suggesting a potential association for females. The increasing T1D incidence in Bavarian youth from 2012 to 2021 highlights the importance of incidence surveillance.

14 November 2024 in Heart
Verified
Journal Article
Closed access
PDF file
FSFlorian Schederecker
Florian Schederecker
CLCarolin T Lehner
Carolin T Lehner
MEMarian Eberl
Marian Eberl
GSGunther Schauberger
Gunther Schauberger
KHKatharina Hansmann
Katharina Hansmann
SKStefanie J Klug
Stefanie J Klug
Background Inconsistent findings about the impact of the COVID-19 pandemic on cardiovascular disease diagnosis and consultations have been reported internationally. The objective of this study was to analyse the impact of the pandemic period (2020–2021) on the incidence rate of coronary heart disease (CHD) compared with the pre-pandemic period (2012–2019) in Bavaria, Germany. Methods We used health claims data of around 9 million statutorily insured residents (≥20 years) of Bavaria, Germany. We calculated quarterly age-standardised incidence rates for men and women diagnosed with CHD using the European Standard Population 2013. Interrupted time series regression models were used to analyse possible pandemic effects on the CHD incidence rates. Results Overall, 797 074 new CHD cases (47% women) were diagnosed from 2012 to 2021. Both pre-pandemic and pandemic incidence rates for women were lower than for men. Regression models showed decreasing incidence rates in the pre-pandemic period in men (−5.2% per year (p.a.), 95% CI: −5.7% to −4.7%) and in women (−6.6% p.a., 95% CI: −7.3% to −6.0%) and seasonal effects (higher in quarter 4 compared with Q1–Q3). During the pandemic period, there was no clear evidence of a level change in the incidence rates both in women and men. However, there are indications of a smaller decline in the incidence during the pandemic compared with the pre-pandemic period, in particular in women (−0.7% p.a., 95% CI: −6.0% to 4.8%) and less prominent in men (−1.7% p.a., 95% CI: −6.0% to 2.8%). Conclusions An overall decreasing CHD incidence rate was observed in men and women in the past decade but no clear impact of the pandemic was seen. These results show the importance of incidence monitoring beyond the pandemics to maintain chronic disease care.